Value in Health

The Translation and Cultural Adaptation of Patient-Reported Outcome Measures
pp. 89-91(3)
Authors: McKenna Stephen P.; Doward Lynda C.

Comments on the ISPOR Task Force Report on Translation and Adaptation of Outcomes Measures: Guidelines and the Need for More Research
pp. 92-93(2)
Author: Lenderking William R.

Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation
pp. 94-104(11)
Authors: Wild Diane; Grove Alyson; Martin Mona; Eremenco Sonya; McElroy Sandra; Verjee-Lorenz Aneesa; Erikson Pennifer

Cost-Effectiveness of Recombinant Human Erythropoietin for Reducing Red Blood Cells Transfusions in Critically Ill Patients
pp. 105-116(12)
Authors: MacLaren Robert; Sullivan Patrick W.

Using Multiple Anchor- and Distribution-Based Estimates to Evaluate Clinically Meaningful Change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) Instrument
pp. 117-127(11)
Authors: Yost Kathleen J.; Sorensen Mark V.; Hahn Elizabeth A.; Glendenning G. Alastair; Gnanasakthy Ari; Cella David

Cardiac Resynchronization Therapy (CRT) in Heart Failure—A Model to Assess the Economic Value of this New Medical Technology
pp. 128-139(12)
Author: Banz Kurt

Excess Mortality, Length of Stay, and Costs Associated with Serious Fungal Infections among Elderly Cancer Patients: Findings from Linked SEER-Medicare Data
pp. 140-148(9)
Authors: Menzin Joseph; Lang Kathleen M.; Friedman Mark; Dixon Deirdre; Marton Jeno P.; Wilson Jerome

The Economic Burden of Anemia in Cancer Patients Receiving Chemotherapy
pp. 149-156(8)
Authors: Lyman Gary H.; Berndt Ernst R.; Kallich Joel D.; Erder M. Haim; Crown William H.; Long Stacey R.; Lee Howard; Song Xue; Finkelstein Stan N.

Validation of the Restless Legs Syndrome Quality of Life Questionnaire
pp. 157-167(11)
Authors: Abetz Linda; Vallow Susan M.; Kirsch Jeff; Allen Richard P.; Washburn Tinna; Earley Christopher J.

Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-Related Quality of Life Measures in a Sample of Patients with Dry Eye
pp. 168-174(7)
Authors: Rajagopalan Krithika; Abetz Linda; Mertzanis Polyxane; Espindle Derek; Begley Carolyn; Chalmers Robin; Caffery Barbara; Snyder Christopher; Nelson J. Daniel; Simpson Trefford; Edrington Timothy

Comments to the Editor on “Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model”
pp. 175-176(2)